Theriva Biologics, Inc.TOVXNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -4.94% |
| 2023 | 2.81% |
| 2022 | 16.88% |
| 2021 | 28.73% |
| 2020 | 9.80% |
| 2019 | -20.03% |
| 2018 | -23.30% |
| 2017 | -26.38% |
| 2016 | 25.63% |
| 2015 | 34.28% |